OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT

OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT

Introduction: Autologous stem cell transplantation (ASCT) following high-dose chemotherapy is applied for patients with relapsed/refractory (r/r) DLBCL. However, prognosis of relapsing DLBCL post-ASCT remained poor until the availability of CAR-T cell treatment. To appreciate this development, unde...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri Taleghani, Urban Novak, Thomas Pabst
Format:	Article
Language:	English
Published:	PAGEPress Publications 2023-04-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	autologous stem cell transplantation (ASCT) diffuse large B-cell lymphoma (DLBCL)
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/5244
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of factors influencing platelet transfusion in children with high-risk stage Ⅳ neuroblastoma undergoing autologous hematopoietic stem cell transplantation
by: FU Xiaoyan, et al.
Published: (2025-07-01)

Autologous stem cell transplantation in multiple myeloma at Chris Hani Baragwanath Academic Hospital
by: Vedanand Rawoo, et al.
Published: (2025-04-01)

Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study
by: Danyang Li, et al.
Published: (2025-02-01)

Retrospective claims data analysis of ASCT characteristics and costs for working-age, multiple myeloma patients in the US, 2017–2019
by: Whanhui Chi, et al.
Published: (2025-01-01)

Enteropathy‐associated T‐cell lymphoma: A population‐based cohort study on incidence, treatment, and outcome in the Netherlands
by: Frederik O. Meeuwes, et al.
Published: (2024-12-01)

Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) DLBCL with CAR T Cell Therapy: A Vodcast and Case Example
by: Gloria Iacoboni, et al.
Published: (2024-12-01)

Is Salvage Autologous Stem Cell Transplantation Still a Viable Treatment Option in Relapsed Myeloma Patients?
by: Luka Čemažar, et al.
Published: (2025-05-01)

Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell lymphoma
by: Jing Ruan, et al.
Published: (2024-12-01)

Case report: pomalidomide as maintenance after salvage autologous stem cell transplantation in a patient with relapsed multiple myeloma
by: S. V. Semochkin, et al.
Published: (2023-12-01)

Trained autologous cytotoxic T-cells derived from PBMCs or splenocytes for immunotherapy of neuroblastoma
by: Xiaofang Wu, et al.
Published: (2025-06-01)

BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma
by: Chengwei Jin, et al.
Published: (2025-12-01)

Association of CAR-T approval on outcomes in patients with diffuse large B-cell lymphoma at the population level in the United States
by: John L. Vaughn, et al.
Published: (2025-04-01)

Autologous engineered T cell receptor therapy in advanced cancer
by: Apostolia M. Tsimberidou, et al.
Published: (2023-12-01)

REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY
by: Ulrike Bacher, et al.
Published: (2021-01-01)

Peripheral EBV antigen-specific T cell is dysfunctional in Epstein–Barr virus positive diffuse large B-cell lymphoma
by: Liang Gao, et al.
Published: (2025-08-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA
by: Gert J. Ossenkoppele, et al.
Published: (2013-02-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Cryopreservation of Hematopoietic Stem Cells for Pediatric Autologous Stem Cell Transplantation
by: Rasika Dhawan Setia, et al.
Published: (2024-11-01)

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma—importance of pre-CAR-T optimization
by: Phoebe Joy Ho, et al.
Published: (2025-08-01)

CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
by: D. A. Fedorenko, et al.
Published: (2014-12-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

Autologous Bone Marrow Transplant in Multiple Myeloma Patient With Bone Marrow Hematopoietic Stem Cell
by: D Santosa, et al.
Published: (2020-12-01)

Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study
by: Cristian Maximiliano Seehaus, et al.
Published: (2024-12-01)

Combined immunochemotherapy in patients with refractory/relapsed classical Hodgkin's lymphoma as a 2<sup>nd</sup> line treatment before autologous hematopoietic stem cell transplantation (preliminary results)
by: A. A. Mamedova, et al.
Published: (2022-07-01)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)

Does CBD induce apoptosis in diffuse large B cell lymphoma?
by: Xu, S.
Published: (2018-08-01)

The single-cell immune landscape of HIV-associated aggressive B-cell lymphoma
by: Xiaomei Zhang, et al.
Published: (2025-04-01)

Preemptive and upfront plerixafor: Safe and effective strategy for patients undergoing autologous stem cell transplant and at high risk for mobilization failure
by: Vipul Sheth, et al.
Published: (2020-01-01)

THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
by: Francesco Maura, et al.
Published: (2016-09-01)

THE FIRST EXPERIENCE OF CLINICAL APPLICATION AUTOLOGICAL MEZENCHIMAL BONE MARROW STEM CELLS FOR REHABILITATION OF RETRACTIVE MYOCARDIAL FUNCTION
by: V. I. Shumakov, et al.
Published: (2003-10-01)

Exploration of biomarkers for predicting the prognosis of patients with diffuse large B-cell lymphoma by machine-learning analysis
by: Shifen Wang, et al.
Published: (2025-08-01)

Application of autologous hemopoietic stem cells in inoperable patients with chronic critical lower limb ischemia
by: I. P. Mikhaylov, et al.
Published: (2022-04-01)

INTRACORONARY AUTOLOGOUS BONE MARROW STEM CELL THERAPY IN DIASTOLIC HEART FAILURE
by: V. I. Shumakov, et al.
Published: (2009-06-01)

IN VITRO ACTIVATION OF EARLY-STAGE APOPTOSIS OF T LYMPHOCYTES BY TRANSFERRING APOPTOTIC AUTOLOGOUS CELL CULTURE COMPONENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: T. Ya. Abramova, et al.
Published: (2018-03-01)

Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants
by: Todorović-Balint Milena, et al.
Published: (2020-01-01)

Rejuvenated Autologous Adult Stem Cells: Emerging Front Runners in the Fight Against Aging and Associated Diseases
by: An Yu, et al.
Published: (2025-07-01)

Autologous hematopoietic stem cell transplantation in patients with POEMS-syndrome: a literature review and own data
by: A. V. Popova, et al.
Published: (2025-03-01)

INFECTION EVENTS IN MULTIPLE MYELOMA DURING THE EARLY PERIOD OF AUTOLOGOUS STEM CELL TRANSPLANTATION
by: Shirkhan Amikishiyev, et al.
Published: (2024-07-01)

Epidemiology of bacteremia after autologous hematopoietic stem cell transplantation in the absence of antibiotic prophylaxis
by: Rima Moghnieh, et al.
Published: (2018-02-01)